2018年8月16日星期四

Glucagon-like peptide 1 receptor: a novel pharmacological target for treating human bronchial hyperresponsiveness

Glucagon-like peptide 1 receptor: a novel pharmacological target for treating human bronchial hyperresponsiveness

P Rogliani, L Calzetta, B Capuani… - American journal of …, 2016 - atsjournals.org
Asthma is associated with several comorbidities, such as type 2 diabetes mellitus, which
may lead to bronchial hyperresponsiveness (BHR). Because glucagon-like peptide (GLP) 1
regulates glucose homeostasis, we pharmacologically investigated the influence of the …


For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com


没有评论:

发表评论